Proteomic Approach Reveals a New Way of Battling Cancer
published in Nature Cell Biology, July 2010

During mitotic cell division, chromosomes that carry genetic information are exactly duplicated to form two daughter cells. The protein Aurora B kinase plays a critical role in the regulation of chromosome segregation during mitosis. Because it is over expressed in tumor cells, a number of chemical inhibitors have been developed as potential anticancer drugs.

Prof. Obuse and his colleagues at the Faculty of Advanced Life Science identified POGZ* as a binding partner for HP1 (Heterochomatin Protein 1) by their leading edge proteomic approach. They revealed that POGZ regulates mitotic progression by activating Aurora B and inducing the dissociation of both HP1 and Aurora B from chromosome arms. The inhibition of interaction between HP1 and POGZ abolished activity of Aurora B kinase, hints that POGZ can be utilized as a possible drug target to selectively kill dividing tumor cells.

The results of this study were first reported in the July issue of Nature Cell Biology.
http://www.nature.com/ncb/index.html

*POGZ (pogo transposable element-derived protein with zinc finger domain)

Contact information:
Prof. Chikashi OBUSE
Faculty of Advanced Life Science, Hokkaido University
E-mail: obuse@sci.hokudai.ac.jp



What's new (Top page)